Page last updated: 2024-11-08

rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate: rhamnolipid biosurfactant from Pseudomonas aeruginosa UG2; active in removing hydrophobic cpds from soil; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoic acid : A glycolipid, an alpha-L-rhamnoside of 3-[(3-hydroxydecanoyl)oxy]decanoic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID162246
CHEBI ID62255
SCHEMBL ID374624
MeSH IDM0227467

Synonyms (19)

Synonym
rphdhd
3-[3-[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxydecanoyloxy]decanoic acid
3-({3-[(6-deoxy-alpha-l-mannopyranosyl)oxy]decanoyl}oxy)decanoic acid
l-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoic acid
37134-61-5
1-(carboxymethyl)octyl 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)decanoate
mono-rhamnolipid
CHEBI:62255
rhamnolipid r1
rhamnolipid 2
decanoic acid, 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-, 1-(carboxymethyl)octyl ester
rhamnosyl-beta-hydroxydecanoyl-beta-hydroxydecanoate
rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate
decanoic acid, 3-[(6-deoxy-.alpha.-l-mannopyranosyl)oxy]-, 1-(carboxymethyl)octyl ester
SCHEMBL374624
rhamnolipid rl1
DTXSID50885662
Q27131721
3-[3-(alpha-l-rhamnopyranosyloxy)decanoyloxy]decanoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
nonionic surfactantA surfactant with an uncharged hydrophilic headgroup.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
alpha-L-rhamnoside
glycolipidAny member of class of 1,2-di-O-acylglycerols joined at oxygen 3 by a glycosidic linkage to a carbohydrate part (usually a mono-, di- or tri-saccharide). Some substances classified as bacterial glycolipids have the sugar part acylated by one or more fatty acids and the glycerol part may be absent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (18.52)18.2507
2000's7 (25.93)29.6817
2010's9 (33.33)24.3611
2020's6 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.89 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]